We also tested the clinical relevance of MPO‐DNA, and a high serological level was closely correlated with synchronous and subsequent liver metastasis and lower OS rates in patients with CRC (Figure 6C; Figure S7C,D, Supporting Information). This evidence concerns the gene MPO and metastasis.